Bluejay Diagnostics Statistics
Total Valuation
BJDX has a market cap or net worth of $1.87 million. The enterprise value is -$3.17 million.
Important Dates
The next estimated earnings date is Monday, March 30, 2026, after market close.
| Earnings Date | Mar 30, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
BJDX has 972,215 shares outstanding. The number of shares has increased by 879.42% in one year.
| Current Share Class | 972,215 |
| Shares Outstanding | 972,215 |
| Shares Change (YoY) | +879.42% |
| Shares Change (QoQ) | +133.02% |
| Owned by Insiders (%) | 3.67% |
| Owned by Institutions (%) | 9.48% |
| Float | 844,438 |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | n/a |
| Forward PS | n/a |
| PB Ratio | 0.19 |
| P/TBV Ratio | 0.31 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Financial Ratio HistoryEnterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 4.88, with a Debt / Equity ratio of 0.02.
| Current Ratio | 4.88 |
| Quick Ratio | 4.61 |
| Debt / Equity | 0.02 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | -8,244.00 |
Financial Efficiency
Return on equity (ROE) is -117.02% and return on invested capital (ROIC) is -71.63%.
| Return on Equity (ROE) | -117.02% |
| Return on Assets (ROA) | -62.76% |
| Return on Invested Capital (ROIC) | -71.63% |
| Return on Capital Employed (ROCE) | -115.28% |
| Weighted Average Cost of Capital (WACC) | 7.70% |
| Revenue Per Employee | n/a |
| Profits Per Employee | -$1.37M |
| Employee Count | 5 |
| Asset Turnover | n/a |
| Inventory Turnover | n/a |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -88.54% in the last 52 weeks. The beta is 0.72, so BJDX's price volatility has been lower than the market average.
| Beta (5Y) | 0.72 |
| 52-Week Price Change | -88.54% |
| 50-Day Moving Average | 2.66 |
| 200-Day Moving Average | 5.53 |
| Relative Strength Index (RSI) | 33.17 |
| Average Volume (20 Days) | 431,846 |
Short Selling Information
The latest short interest is 24,997, so 2.57% of the outstanding shares have been sold short.
| Short Interest | 24,997 |
| Short Previous Month | 25,685 |
| Short % of Shares Out | 2.57% |
| Short % of Float | 2.96% |
| Short Ratio (days to cover) | 0.19 |
Income Statement
| Revenue | n/a |
| Gross Profit | n/a |
| Operating Income | -6.92M |
| Pretax Income | -6.85M |
| Net Income | -6.85M |
| EBITDA | -6.84M |
| EBIT | -6.92M |
| Earnings Per Share (EPS) | -$15.25 |
Full Income StatementBalance Sheet
The company has $5.16 million in cash and $129,558 in debt, with a net cash position of $5.04 million or $5.18 per share.
| Cash & Cash Equivalents | 5.16M |
| Total Debt | 129,558 |
| Net Cash | 5.04M |
| Net Cash Per Share | $5.18 |
| Equity (Book Value) | 5.98M |
| Book Value Per Share | 9.88 |
| Working Capital | 4.34M |
Full Balance SheetCash Flow
In the last 12 months, operating cash flow was -$6.05 million and capital expenditures -$173,735, giving a free cash flow of -$6.23 million.
| Operating Cash Flow | -6.05M |
| Capital Expenditures | -173,735 |
| Free Cash Flow | -6.23M |
| FCF Per Share | -$6.41 |
Full Cash Flow StatementMargins
| Gross Margin | n/a |
| Operating Margin | n/a |
| Pretax Margin | n/a |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
